Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Potent antiviral activity and favorable safety of doravirine in HIV-1-infected patients

March 14, 2014

Favorable 24-week virological efficacy of BMS-663068 supports continued development

March 14, 2014

Seattle BioMed awarded NIH grant to develop vaccine against HIV

March 11, 2014

AiCuris patents new RT inhibitors for HIV infection

March 10, 2014

Vaginal dapivirine effectively protects against HIV challenge

March 6, 2014

Novel HIV integrase inhibitors disclosed by Bristol-Myers Squibb

March 5, 2014

New HIV attachment inhibitors designed at Bristol-Myers Squibb

Feb. 26, 2014

Sirenas Marine Discovery receives SBIR grant for its HIV small-molecule therapeutic

Feb. 25, 2014

Bionor Pharma reports data from phase I trial of Vacc-C5

Feb. 25, 2014

Bristol-Myers Squibb discloses new agents for HIV infection

Feb. 24, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...